Immunophenotypic analyses of CD34+ cell subsets in bone marrow from HIV-infected patients during highly-active antiretroviral therapy

European Journal of Clinical Investigation

Volumn 32, Issue 7, 2002, Pages 535-540

  Muller F ^a   Tjonnfjord G E ^a   Nordoy I ^a   Kvale, D ^a   Mellbye, O J ^a   Aukrust, Pål ^a,b   Froland S S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Bone marrow; CD34+ cells; HAART; Lymphopoiesis

Indexed keywords

ANTIRETROVIRUS AGENT; CD34 ANTIGEN; CELL MARKER; IMMUNOGLOBULIN G; INDINAVIR; LAMIVUDINE; NELFINAVIR; PROTEINASE INHIBITOR; ZIDOVUDINE;

ADULT; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

ADULT; ANTIGENS, CD34; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BETA 2-MICROGLOBULIN; BONE MARROW CELLS; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; IMMUNOGLOBULIN G; IMMUNOPHENOTYPING; INDINAVIR; LAMIVUDINE; LEUKOCYTE COUNT; MALE; MIDDLE AGED; STAVUDINE; T-LYMPHOCYTE SUBSETS; ZIDOVUDINE;

EID: 0036997848     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.2002.00995.x     Document Type: Article

References (34)

1. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
2. Calenda V, Chermann JC, Hoxie JA. The effects of HIV on hematopoiesis. Eur J Haematol 1992;48:181-6.
3. Moses A, Nelson J, Bagby GC. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 1998;91:1479-95.
4. Louache F, Henri A, Bettaieb A, Oksenhendler E, Raguin G, Tulliez M et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992;80:2991-9.
5. Marandin A, Katz A, Oksenhendler E, Tulliez M, Picard F, Vainchecker W et al. Loss of primitive progenitors in patients with human immunodeficiency virus infection. Blood 1996;88:4568-78.
6. + hematopoietic progenitors. Pathobiology 1996;64:53-8.
7. Gulick RM. HIV treatment strategies. JAMA 1998;279:957-9.
8. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, Haynes BF et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998;396:690-5.
9. Bucy RP, Hockett RD, Derdeyn CA, Saag MS, Squires K, Sillers M et al. Initial increase in blood CD4(+) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J Clin Invest 1999;103:1391-8.
10. + lymphocyte apoptosis in HIV+ patients. Clin Exp Immunol 2000;120:101-6.
11. + peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor. Blood 1994;84:2795-801.
12. Aukrust P, Müller P, Lien E, Nordøy I, Liabakk N-B, Kvale D et al. Tumor necrosis factor (TNF) system in human immunodeficiency virus-infected patients during highly active antiretroviral therapy (HAART): Persistent TNF activation is associated with virologic and immunologic treatment failure. J Infect Dis 1999;179:74-82.
13. Haynes BF, Denning SM, Singer KH, Kurtzberg J. Ontogeny of T-cell precursors: a model of the initial stages of human T-cell development. Immunol Today 1989;10:87-91.
14. Terstappen LWMM, Huang S, Picker LJ. Flow cytometric assessment of human T-cell differentiation in thymus and bone marrow. Blood 1992;79:666-77.
15. Pontvert-Delucq S, Breton-Gorius J, Schmitt C, Baillou C, Guichard J, Naijam A et al. Characterization and functional analysis of adult human bone marrow cells subsets in relation to B-lymphoid development. Blood 1993;82:417-9.
16. Steen R, Tjønnfjord GE, Groseth LA, Egeland T. Characteristics of haemopoietic progenitor cells related to CD34 epitope class expression. Eur J Haematol 2000;64:245-51.
17. Diamondstone LS, Tollerud DJ, Fuchs D, Wachter H, Brown LM, Maloney E et al. Factors influencing serum neopterin and β2-microglobulin levels in healthy controls. J Clin Immunol 1994;14:368-74.
18. Broxmeyer HE, Sherry B, Cooper S, Lu L, Maze R, Beckmann MP et al. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression. J Immunol 1993;150:3448-58.
19. Lane HC. Interferons in HIV and related diseases. AIDS 1994;8:S19-S23.
20. Rosenberg ZF, Fauci AC. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol Today 1990;11:176-81.
21. + stem cells in advanced human immunodeficiency virus type 1 disease. J Infect Dis 2000;181:148-57.
22. +) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood 1992;79:2680-7.
23. Dam Nielsen S, Kjaer Ersboll A, Mathiesen L, Nielsen JO, Hansen JE. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis 1998;178:1299-305.
24. Isgro A, Mezzaroma I, Aiuti A, De Vita L, Franchi F, Pandolfi F et al. Recovery of hematopoietic activity in bone marrow from human immunodeficiency virus type 1-infected patients during highly active antiretroviral therapy. AIDS Res Hum Retroviruses 2000;16:1471-9.
25. + cells. Blood 2000;96:2735-9.
26. + cell colony-forming units from HIV type 1-infected patients. AIDS Res Hum Retroviruses 1999;15:551-9.
27. + cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow. J Hematother 1994;3:253-62.
28. Andrews RG, Singer JW, Bernstein ID. Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties. J Exp Med 1989;169:1721-31.
29. Kuritzkes DR. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor. Clin Infect Dis 2000;30:256-60.
30. Coffey MJ, Phare SM, George S, Peters-Golden M, Kazanjian PH. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J Clin Invest 1998;102:663-70.
31. Pitrak DL, Tsai HC, Mullane KM, Sutton SH, Stevens P. Accelerated neutrophil apoptosis in the acquired immunodeficiency syndrome. J Clin Invest 1996;98:2714-9.
32. Faraj A, Schinazi RF, Xie MY, Gosselin G, Perigaud C, Imbach JL et al. Selective protection of toxicity of 2′,3′-dideoxypyrimidine nucleoside analogs by beta-D-uridine in human granulocyte-macrophage progenitor cells. Antiviral Res 1996;29:261-7.
33. Thiebot H, Louache F, Vaslin B, de Revel T, Neildez O, Larghero J et al. Early and persistent bone marrow hematopoiesis defect in simian/human immunodeficiency virus-infected macaques despite efficient reduction of viremia by highly active antiretroviral therapy during primary infection. J Virol 2001;75:11594-602.
34. Morris L, Binley JM, Clas BA, Bonhoeffer S, Astill TP, Kost R et al. HIV-1 antigen-specific and - nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 1998;188:233-45.